Our weight loss program in Lubbock, Texas uses GLP-1 medications including Ozempic, Mounjaro, Wegovy, Zepbound and more to help patients lose weight
BPC-157 demonstrates exceptional safety in animal toxicology studies, with comprehensive evaluations in mice, rats, rabbits, and dogs failing to establish a lethal dose (LD) across wide dose ranges extending from standard research doses (6 g/kg) to levels exceeding 1000-fold higher concentrations (20 mg/kg), with no evidence of acute toxicity, organ-specific damage, or systemic adverse effects even following repeated high-dose administration
For instance, Tirzepatide is a dual GIP and GLP-1 receptor agonist, providing a unique approach compared to traditional GLP-1 agonists
For those committed to long-term treatment and lifestyle changes, weight loss can reach up to 15% of total body weight over a year or more
The risk is amplified when combined with semaglutide, necessitating adjustments to medication doses under medical supervision
Fixed pricing regardless of the dosage